Non-Hormonal Treatment for Hot Flashes: How the New Class of Medicines Works

Hot flashes are wearing you down, but hormone therapy isn't an option for you, or you simply don't want it. And the answer you keep hearing is “Be patient, it will pass.” The problem is that “it will pass” can mean years. The good news is that non-hormonal treatment for hot flashes has changed: a few years ago a fundamentally different class of medicines appeared, one that works on the brain's temperature centre rather than replacing hormones.
This guide explains, in plain language, why hot flashes happen, how this new class works, what the clinical trials actually showed (in numbers, not advertising percentages), what is known about safety, and who might want to discuss it with a doctor. It is not a recommendation to take any particular medicine. The choice of treatment is always individual.
How long do hot flashes last?
“It will pass” sounds reassuring until you look at the data. In the large American SWAN study (Study of Women's Health Across the Nation), the median duration of hot flashes and night sweats was more than 7 years. For women whose hot flashes started before their final period, the duration was even longer.
Seven years is a long time to sleep badly, wake up drenched, and lose focus in meetings. Hot flashes are not a matter of willpower. Waiting it out is a choice some women make, but it shouldn't be the only option offered.
What actually happens during a hot flash
A hot flash is a malfunction of the body's “thermostat”, a temperature-control centre in a part of the brain called the hypothalamus.
Normally, estrogen helps keep certain nerve cells in this centre in check. When estradiol (the main form of estrogen) falls during the menopause transition, these neurons lose their brake and release too much of a signalling molecule called neurokinin B. The brain then wrongly concludes that you are overheating and launches its cooling programme: blood vessels in the skin widen, you flush, you break into a sweat, and your heart may start pounding. When this happens at night, it is what we call night sweats.
In other words, a hot flash is not “in your head” in the dismissive sense. It is in your head in the most literal, biochemical sense, and that is exactly what makes it treatable. “It's not your character, it's biochemistry, and that biochemistry has a target.”
The new class of non-hormonal medicines: a different mechanism
The new medicines block neurokinin receptors right in this temperature-control centre. By dampening the excess neurokinin B signal, they aim to calm the faulty thermostat.
It is important to understand what they are not. They don't replace estrogen and don't act on the same target as hormone therapy. They work on a different link in the same chain. This is “not ‘hormones-lite’, but a different mechanism.”
What the clinical trials showed
Two double-blind trials, about 800 women
In two double-blind trials published in JAMA in 2024, about 800 women aged 40 to 65 received either one medicine from this class or a placebo. “Double-blind” means neither the participants nor the researchers knew who was getting what, which makes the results more reliable.
By week 12, the number of hot flashes had fallen by about 3 more per day than on placebo. Sleep and quality of life improved too.
A one-year trial
In a 52-week trial published in JAMA Internal Medicine in 2025, the difference from placebo at week 12 was about 1.6 hot flashes per day.
Why the placebo effect matters here
There is an honest detail that advertising tends to skip: placebo also helps a lot. In these trials, women on placebo also had noticeably fewer hot flashes. That is why the effect of a treatment should be judged by the difference from placebo, not by impressive-looking percentages of improvement.
Another medicine in the same class
For another medicine of this class, the effect was confirmed in the SKYLIGHT series of trials. However, in a study among women in East Asia the result was less clear. Data across different populations are still more limited than one would like.
What we know about safety
On the positive side, the one-year trial found no endometrial hyperplasia (abnormal thickening of the lining of the womb, a known concern with estrogen given without protection) and no significant changes in bone density.
On the other side:
- Side effects were more frequent than on placebo: about 30% versus 15%. The most common were sleepiness, fatigue and headache.
- The liver: some medicines in this class carry specific liver warnings, so your doctor may order blood tests before and during treatment.
- Long-term data are still limited. We know less about use over many years than we do about hormone therapy.
Who might consider non-hormonal treatment for hot flashes
This option may matter most for two groups of women:
- those for whom hormone therapy isn't suitable for medical reasons (see which HRT contraindications are real and which are myths);
- those who don't want hormone therapy for personal reasons.
Whether this particular option suits you is a decision for your doctor, taking into account your liver health, the other medicines you take and your medical history. Availability and approval also differ from country to country.
Is it better than HRT?
No illusions here. For most women, hormone therapy remains the most effective treatment for hot flashes, and there are few large head-to-head comparisons with the new class. This is “not a ‘better replacement’, but one more tool in the kit.”
If you have been told “no hormones” without a clear explanation, it's worth asking why. Sometimes the reason is a real contraindication. Sometimes it is a myth, or an outdated view of the evidence, like the idea that our grandmothers managed without HRT.
Questions to ask your doctor
- Is hormone therapy really unsuitable for me, and if so, why exactly?
- Is a non-hormonal medicine of this new class available and approved where I live?
- Given my liver, my other medicines and my history, would it be appropriate for me?
- What tests would I need before starting and during treatment?
- How will we judge whether it's working, and when?
Frequently asked questions
How long do hot flashes last?
In the large SWAN study, the median duration of hot flashes and night sweats was more than 7 years. For women whose hot flashes began before their final period, they lasted even longer.
Is there a non-hormonal treatment for hot flashes?
Yes. In recent years a new class of non-hormonal medicines has appeared that blocks neurokinin receptors in the brain's temperature-control centre. It doesn't replace estrogen; it works through a different mechanism. Whether it suits you is a decision for your doctor.
How do the new non-hormonal hot flash medicines work?
When estrogen falls, certain neurons in the hypothalamus release too much neurokinin B, and the brain wrongly decides the body is overheating. The new class blocks neurokinin receptors in this centre, calming the faulty “thermostat”.
Are non-hormonal hot flash medicines safe?
In a one-year trial there was no endometrial hyperplasia and no significant change in bone density. Side effects such as sleepiness, fatigue and headache were more common than on placebo (about 30% vs 15%). Some medicines in the class carry liver warnings, so blood tests may be needed, and long-term data are limited.
Are non-hormonal medicines as effective as HRT for hot flashes?
For most women, hormone therapy remains the most effective treatment, and there are few large direct comparisons. The new class is one more option, not a better replacement.
The bottom line
Hot flashes aren't a weakness and aren't “just age.” They have a clear biological mechanism, and that mechanism now has a non-hormonal target. The new class of medicines is a real option for women who can't or won't use hormone therapy, with modest but measurable effects, known side effects and limited long-term data. The right choice is the one made with your doctor, based on your health and your priorities.
If you want your symptoms, hormones, sleep and biomarkers looked at as one picture, that is what the Personalised Method is built around.
Want to find the option that fits you? Apply for a Strategic Session.
Sources
- Pinkerton JV et al. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA, 2024. pubmed.ncbi.nlm.nih.gov/39172446
- Panay N et al. Elinzanetant, OASIS-3, 52 weeks. JAMA Internal Medicine, 2025. pubmed.ncbi.nlm.nih.gov/40920404
- Cucinella L et al. Profile of safety and efficacy of fezolinetant. Expert Review of Clinical Pharmacology, 2025. pubmed.ncbi.nlm.nih.gov/40253593
- Avis NE et al. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition (SWAN). JAMA Internal Medicine, 2015. pubmed.ncbi.nlm.nih.gov/25686030
- Educational background: Women's Health and Wellness Program, Harvard Medical School Executive Education.
This article is for educational purposes only and does not replace medical advice. Decisions about treatment should be made individually, with your doctor.
Apply for a Strategic Session
A short application. I will reply personally within 1–2 working days.

.jpeg)
